Italy Neurology Clinical Trials Market Analysis

Italy Neurology Clinical Trials Market Analysis

$ 3999

The Italy Neurology Clinical Trials market is projected to grow from $125.5 Mn in 2022 to $185.5 Mn by 2030, registering a CAGR of 5% during the forecast period of 2022 - 2030. The market will be driven by the rising demand for novel therapies for neurological disorders and the supportive regulatory climate in Italy. The market is segmented by phase, by study design & by indication. Some of the major players include AstraZeneca, Chiesi Farmaceutici & Menarini.

ID: IN10ITCT005 CATEGORY: Clinical Trials GEOGRAPHY: Italy AUTHOR: Vidhi Upadhyay

Buy Now

Italy Neurology Clinical Trials Market Executive Summary

The Italy Neurology Clinical Trials market is projected to grow from $125.5 Mn in 2022 to $185.5 Mn by 2030, registering a CAGR of 5% during the forecast period of 2022 - 2030. Italy has a large and mature pharmaceutical market, with high levels of domestic consumption of both prescription and over-the-counter drugs. There are around 5000 pharmaceutical firms in Italy, including both large and small businesses. Alzheimer's and dementia fatalities in Italy reached 41,445 in 2020, accounting for 7.64% of total deaths, according to the most recent WHO statistics. In 2020, Italy accounted for 3.3% of worldwide clinical trial activity.

The neurology clinical trials landscape in Italy is highly dynamic, with several clinical studies taking place around the nation. Italy has a high frequency of neurological illnesses, including Alzheimer's disease, Parkinson's disease, multiple sclerosis, and epilepsy. As academics and pharmaceutical firms attempt to create novel treatments and cures for these disorders, there has been a surge in interest in neurology clinical trials in Italy. There is a rising interest in discovering novel medicines for neurological illnesses, and several clinical studies are now being conducted to assess the safety and effectiveness of various treatments.

Italy Neurology Clinical Trials Market

Market Dynamics

Market Growth Drivers

The regulatory climate in Italy is largely supportive of clinical trials, with the Italian Medicines Agency (AIFA) in charge of regulating clinical trial permission and conduct in the nation. AIFA has put in place a number of initiatives to help researchers and sponsors through the clinical trial approval procedure. Moreover, Italy has a high frequency of neurological illnesses, including Alzheimer's disease, Parkinson's disease, multiple sclerosis, and epilepsy. It has led to an increasing interest in neurology clinical trials in Italy. Italy additionally has a good research infrastructure, with many international universities, research organizations, and healthcare facilities, as well as a rising demand for novel therapies for neurological disorders, such as gene therapies and stem cell therapies leading to market expansion.

Market Restraints

CNS medicines and injections have a number of adverse effects, including loneliness and difficulty sleeping, raised blood pressure, and nerve damage, which could restrict their usage in the future years. Other factors such as regulatory complexity, insufficient money, and patient recruiting issues hinder the country's clinical trial expansion. Moreover, the COVID-19 pandemic has disrupted clinical studies in Italy, causing delays and interruptions which are yet to be recovered. Italy is likewise competing with other nations for clinical studies. Because of their vast population bases, increased prevalence of neurological disorders, and better healthcare infrastructure and investment, emerging nations such as India, China, and Brazil provide tempting market potential and good competition to Italy’s market expansion.

Competitive Landscape

Key Players

  • Novartis
  • Merck & Co.
  • Biogen
  • Sanofi
  • Eli Lilly and Company
  • AstraZeneca.
  • Chiesi Farmaceutici (ITA)
  • Menarini (ITA)
  • Dompé Farmaceutici (ITA)
  • Angelini Pharma (ITA)
  • Recordati (ITA)

Notable Deals

In June 2022, Biogen invested more than $700 million in Alectos' preclinical oral Parkinson's medication to strengthen its pipeline.

Healthcare Policies and Regulatory Landscape & Reimbursement Scenario

The Italian Medicines Agency is the regulatory entity in charge of clinical trials in Italy (AIFA). AIFA is in charge of evaluating, authorising, and monitoring clinical studies in Italy, particularly neurology clinical trials. AIFA guarantees that clinical trials are done in accordance with ethical and legal standards and that participants' safety and rights are maintained.

There are many kinds of financing available in Italy for neurology clinical trials. The Italian government funds research via a variety of entities, including the Ministry of Health, the National Institute of Health (ISS), and the National Research Council (CNR). Moreover, private organisations and charities support clinical trials and research initiatives. Moreover, Italian pharmaceutical and biotech corporations play an important role in supporting neurology clinical studies in Italy. These corporations make significant investments in the research and development of novel medicines and treatments for neurological illnesses, and they often fund clinical studies to evaluate the safety and effectiveness of their medications.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Clinical Trials Regulation in Country
1.6 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share
4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company Overview Product Applications and Services Recent Developments Partnerships Ecosystem Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation

6. Methodology and Scope

Neurology Clinical Trials Market Segmentation

By Phase (Revenue, USD Billion):

  • Phase I
  • Phase II
  • Phase III
  • Phase IV

By Study Design Outlook (Revenue, USD Billion):

  • Epilepsy
  • Parkinson's Disease (PD)
  • Huntington's Disease
  • Stroke
  • Traumatic Brain Injury (TBI)
  • Amyotrophic Lateral Sclerosis (ALS)
  • Muscle regeneration
  • Others

By Indication Outlook (Revenue, USD Billion):

  • Interventional
  • Observational
  • Expanded Access

Insights10 will provide you with the reports within 10 key parameters which are:

  1. Market Overview
  2. Market Growth Drivers & Restraints
  3. Epidemiology of Disease Type
  4. Market Segmentation
  5. Market Share
  6. Competitive Landscape
  7. Key Company Profiles
  8. Healthcare Policies & Regulatory Framework
  9. Reimbursement Scenario
  10. Factors Driving Future Growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.


Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:



Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and  Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.

We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.



Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing the regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue/volume
  • ​Analyzing current needs and determining penetration to estimate the market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.

Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.

The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy of this report, please complete the form below.

We value your inquiry and offer free customization with every report to fulfil your exact research needs.

This report addresses

  • Intelligent insights to take informed business decisions
  • Qualitative, acute and result oriented market analysis
  • Market size and forecasts from 2022 to 2030
  • Opportunities for expansion and in-depth market analysis
  • Segmentation and regional revenue forecasts
  • Analysis of the market share and competitive landscape
  • Strategic Recommendations to chart future course of action
  • Comprehensive Market Research Report in PDF and PPT formats

Need more?

  • Ask our analyst how this study was put together to learn more
  • Discuss additional requirements as part of the free customisation
  • Add more countries or regions to the scope 
  • Get answers to specific business questions 
  • Develop the business case to launch the product
  • Find out how this report may influence your business revenue
Last updated on: 14 March 2023
Updated by: Bhanu Pratap Singh

Related reports (by category)

Related reports (by geography)

subscribe to our newsletter